Clinical Trial

Standard Versus Short Course Prophylactic Antibiotic in Femur and Tibia Shaft Fractures Managed With Intramedullary Interlocking Nail

Completed
View on ClinicalTrials.gov →
Summary
Long-bone fractures, particularly of femur and tibia, are common following fall injury and road traffic accidents.1,2 The standard treatment is "intramedullary nailing," where a metal rod is inserted into the center of the bone to hold it in place.3,4 However, surgical site infection (SSI) and fracture related infection (FRI) remain significant complications of nailing that delay healing and increase healthcare costs.5,6 To prevent these infections, doctors give patients antibiotics around the time of surgery. However, there is ongoing debate about how long these antibiotics should be continued. In many regions, patients receive antibiotics for several days, but recent evidence suggests that a shorter course may be just as effective and could reduce the risk of antibiotic resistance and side effects. Study Question The goal of this study is to determine if a one-day (short) course of antibiotics is as effective as a three-day (standard) course in preventing infections after bone-nailing surgery. Hypotheses Null Hypothesis (H0): There is no significant difference in the incidence of infection or short-term clinical outcomes between the one-day (short-course) and three-day (standard-course) antibiotic protocols. Alternative Hypothesis (H1): There is a significant difference in the incidence of infection or short-term clinical outcomes between the one-day (short-course) and three-day (standard-course) antibiotic protocols.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-04-21.
Trial Details
NCT Number NCT07554079
Lead Sponsor Kathmandu University School of Medical Sciences
Conditions Fracture Femur, Fracture Tibia, Surgical Site Infection (SSI), Antibiotic, Antibiotic Prescription
Enrollment 56 participants
Start Date 2024-02-15
Primary Completion 2025-11-08 (estimated)
Study Completion 2025-11-08 (estimated)
Updated on ClinicalTrials.gov 2026-05-04